EGFR and sarcomatoid carcinoma: In lung adenocarcinoma patients experiencing disease progression to EGFR-TKI, histological transformation into small-cell lung cancer (SCLC) [4,5], squamous-cell carcinoma (SqCC) [6], and sarcomatoid carcinoma are known [7,8,9].